Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Drug Resistance Equipment Supplied In Europe
18 equipment items found
Manufactured by:inomed Medizintechnik GmbH based inEmmendingen, GERMANY
In combination with the sEEG-Box, it is possible to perform RF treatments via sEEG electrodes. sEEG (stereoelectroencephalography) is an invasive, diagnostic procedure for patients with drug-resistant ...
Manufactured by:Copan Italia s.p.a. based inBrescia, ITALY
FecalSwab is intended to collect fecal specimens and preserve enteric pathogenic bacteria’s viability during transport to the testing laboratory. In the laboratory, FecalSwab™ samples are processed using standard clinical laboratory operating procedures for ...
Manufactured by:Sage Products LLC based inCary, ILLINOIS (USA)
Using a basin to clean your patients may increase the risk of infection. Studies have shown basins are often contaminated with bacteria, including multi-drug resistant organisms and gram-negative bacilli.1,2 Our rinse-free barrier cream cloths are the #1 hospital brand3 and provide the ideal barrier for all clinical ...
by:CHROMagar based inParis, FRANCE
CHROMagar™ Acinetobacter is a selective and differential chromogenic culture medium, intended for use in the qualitative direct detection of colonization with Acinetobacter to aid in the prevention and control of Acinetobacter, drug-susceptible or multi-drug resistant (MDR), in healthcare settings. The test is performed with rectal swabs, ...
by:CHROMagar based inParis, FRANCE
Performance: β-Lactamase production (ESBL, AmpC, carbapenemase) is the most common mechanism of β-lactam drug resistance in Gram negative bacteria. Each of the involved mechanisms can be plasmid-encoded and transfer horizontally. Moreover, plasmids continuously gather other antibiotic resistance determinants, ultimately closing to ...
by:Pureims B.V. based inRoden, NETHERLANDS
This could more rapidly decrease contagiousness by sterilizing the upper airways of patients with ’open’ (smear positive) TB, potentially even of otherwise drug resistant TB. In addition, Amikacin Cyclops™ offers TB patients an easier and much more convenient administration than infusion or injection. A fast reduction of contagiousness and new, ...
Manufactured by:Scancell based inOxford, UNITED KINGDOM
Glycosylation is increasingly recognised as a modulator of the malignant phenotype of cancer cells, where the interaction between cells and the tumour micro-environment is altered to facilitate processes such as drug resistance, metastasis and immune evasion. Antibodies recognising tumour-associated glycans could therefore have excellent therapeutic ...
Manufactured by:CanVirex AG based inBasel, SWITZERLAND
Conventional cancer treatments such as surgery, chemo-, or radiotherapy are restricted to local therapy or by dose-limiting toxicities and may induce drug resistance during treatment. In recent years, the field of immunotherapy has launched a paradigm shift in cancer therapy and for the first time could demonstrate a potential for long-term survival of patients ...
Manufactured by:Bayer AG based inLeverkusen, GERMANY
Traditionally, many small molecule drugs follow the same basic mechanism of action to treat diseases: They inhibit the function of a target protein that has an active role in a disease. To do so, they require a tractable active binding site to occupy, which will result in protein function inhibition like blocking its enzymatic activity. But traditional small molecules can only block one single ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Tulmimetostat is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target coverage through extended on-target residence time. EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a histone protein, leading to the suppression of gene expression. Some cancers depend on an abnormal pattern of gene expression and re-direct EZH2 to genes ...
by:Procarta Biosystems Ltd based inNorwich, UNITED KINGDOM
Proprietary nanoparticles deliver an oligonucleotide inside the bacterial pathogen. The oligonucleotide acts as a Transcription Factor Decoy (TFD): it contains the binding site of a transcription factor that controls a large set of genes required for the survival of the bacterium. The TFD acts as a competitive inhibitor to prevent these genes being turned on and so prevents growth and treats the ...
Manufactured by:MerLion Pharmaceuticals GmbH based inBerlin, GERMANY
Finafloxacin is a novel candidate for the treatment of multiple, life-threatening infection indications, like complicated urinary tract infections (cUTIs). Coming from a well-known and well understood “workhorse” class of antibiotic, its unique properties in activity, safety and flexible dosing regimen options, clearly distinguish finafloxacin from other, existing therapies, offering ...
Manufactured by:Immunethep, SA based inCantanhede, PORTUGAL
Immunethep has developed an anti-bacterial immunotherapy based on the discovery of a virulence mechanism shared by a set of different pathogenic ...
Manufactured by:Nanosonics, Inc. based inSydney, AUSTRALIA
Every day, 82,000 patients are protected from the risk of cross contamination because the ultrasound probe has been high-level disinfected with the trophon ...
Manufactured by:Roche Diagnostics International AG based inRotkreuz, SWITZERLAND
GenMark’s ePlex® Blood-Culture Identification (BCID) Panels provide broad coverage of organisms that can lead to sepsis along with their resistance genes. This broad coverage means that about 95% of currently identified bloodstream infections can be detected early with the ePlex BCID Panels, compared to other panels that detect significantly fewer sepsis-causing bacteria and fungi ...
Manufactured by:Datar Cancer Genetics based inGuildford, UNITED KINGDOM
CancertrackTM is a non-invasive blood based investigation that detects cancer derived biomarkers with ultra-high precision, specificity and reliability. CancertrackTM can be used to monitor the disease /recurrence or changes in the tumor characteristics, as often as necessary, without the cost, risk and consequences of radiation from scans, hospitalisation, anaesthesia or painful surgical ...
by:Diasorin based inSALUGGIA, ITALY
The VERIGENE System enables clinicians to rapidly identify the pathogens responsible for some of the most complex, costly, and deadly infectious ...
Manufactured by:Nyxoah SA based inMont-Saint-Guibert, BELGIUM
Genio is the disruptive sleep apnea solution for patients who suffer from moderate to severe Obstructive Sleep Apnea or OSA. Genio is the world’s first and unique battery-free, leadless, full body MR conditional and minimally invasive neurostimulator that was designed and developed with users in mind. By stimulating the hypoglossal nerve bilaterally, Genio maintains your upper airway open ...